1. Home
  2. COHN vs GRML Comparison

COHN vs GRML Comparison

Compare COHN & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$11.99

Market Cap

54.3M

Sector

Finance

ML Signal

HOLD

GRML

Greenland Mines Ltd. Common Stock

N/A

Current Price

$0.29

Market Cap

51.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
COHN
GRML
Founded
1999
N/A
Country
United States
United States
Employees
N/A
5
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
54.3M
51.5M
IPO Year
2003
2022

Fundamental Metrics

Financial Performance
Metric
COHN
GRML
Price
$11.99
$0.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.9K
3.5M
Earning Date
05-01-2026
05-13-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
N/A
EPS
0.42
N/A
Revenue
$275,564,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.98
N/A
Revenue Growth
246.19
N/A
52 Week Low
$8.16
$0.27
52 Week High
$32.60
$0.55

Technical Indicators

Market Signals
Indicator
COHN
GRML
Relative Strength Index (RSI) 45.00 35.31
Support Level $10.64 $0.27
Resistance Level $16.48 $0.44
Average True Range (ATR) 0.53 0.03
MACD 0.35 -0.00
Stochastic Oscillator 76.25 20.62

Price Performance

Historical Comparison
COHN
GRML

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: